SCHEMBL17099543

SCHEMBL17099543

COC(=O)N1c2cc(Br)ccc2CC1(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
FFAR4 Q5NUL3 1/20 0.35
HSD17B3 P37058 3/20 0.35
ABHD6 Q9BV23 1/20 0.34
OPRM1 P35372 1/20 0.34
OPRD1 P41143 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33
TUBB3 Q13509 1/20 0.33
TUBB2A Q13885 1/20 0.33
TUBB8 Q3ZCM7 1/20 0.33
TUBA3E Q6PEY2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17099540 0.83 FSHR (0.39) FFAR4HSD17B3LMNAGFERKDM4E
SCHEMBL17099539 0.80 HTT (0.42) SMN1; SMN2
SCHEMBL23123817 0.76 ABHD6 (0.41) NPC1RAB9ASMN1; SMN2HSD17B3ABHD6
SCHEMBL29789867 0.76 ABHD6 (0.41) NPC1RAB9ASMN1; SMN2HSD17B3ABHD6
SCHEMBL12036060 0.74 FFAR4 (0.44) NPC1RAB9ASMN1; SMN2FFAR4LMNA
SCHEMBL30350644 0.74 FFAR4 (0.44) NPC1RAB9ASMN1; SMN2FFAR4LMNA
SCHEMBL29209110 0.72 OPRM1 (0.39) SMN1; SMN2OPRM1OPRD1CYP1A2CYP3A4
SCHEMBL3450078 0.71 RORC (0.39) NPC1RAB9AABHD6HDAC1
SCHEMBL17099458 0.67 HTR2A (0.43) SMN1; SMN2HSD17B3LMNAPMP22NPSR1
SCHEMBL25959828 0.67 KDM4E (0.43) RAB9AHSD17B3ABHD6TUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015143376-A1 NOVEL COMPOUNDS FOR THE TREATMENT OF CYSTIC FIBROSIS NIVALIS THERAPEUTICS, INC. (US) 2015-09-24 WO disclosed